195 related articles for article (PubMed ID: 24097977)
1. Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor.
Lo NC; Turner NA; Cruz MA; Moake J
J Biol Chem; 2013 Nov; 288(46):33118-23. PubMed ID: 24097977
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
Liu F; Huang J; Sadler JE
Blood; 2011 Sep; 118(12):3392-8. PubMed ID: 21816831
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.
Pysher TJ; Siegler RL; Tesh VL; Taylor FB
Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894
[TBL] [Abstract][Full Text] [Related]
7. Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis.
Turner NA; Moake J
PLoS One; 2013; 8(3):e59372. PubMed ID: 23555663
[TBL] [Abstract][Full Text] [Related]
8. [ADAMTS13-Mediated Proteolytic Cleavage of Unusually Large von Willebrand Factor Polymers on Endothelial Cells in the Absence of Fluid Shear Stress].
Zhao SC; Li H; Wang M; Zhao YH; Li XJ; Jin SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):532-540. PubMed ID: 38660863
[TBL] [Abstract][Full Text] [Related]
9. Effect of tranexamic acid on endothelial von Willebrand factor/ADAMTS-13 response to in vitro shock conditions.
Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2023 Feb; 94(2):273-280. PubMed ID: 36322025
[TBL] [Abstract][Full Text] [Related]
10. Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
Turner N; Nolasco L; Moake J
Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602
[TBL] [Abstract][Full Text] [Related]
11. Conformational stability and domain unfolding of the Von Willebrand factor A domains.
Auton M; Cruz MA; Moake J
J Mol Biol; 2007 Feb; 366(3):986-1000. PubMed ID: 17187823
[TBL] [Abstract][Full Text] [Related]
12. Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF
J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.
Huang J; Motto DG; Bundle DR; Sadler JE
Blood; 2010 Nov; 116(18):3653-9. PubMed ID: 20644116
[TBL] [Abstract][Full Text] [Related]
15. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
Nishio K; Anderson PJ; Zheng XL; Sadler JE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.
Zhou Z; Dong JF
Curr Vasc Pharmacol; 2012 Nov; 10(6):762-6. PubMed ID: 22022775
[TBL] [Abstract][Full Text] [Related]
17. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions.
Dong JF
J Thromb Haemost; 2005 Aug; 3(8):1710-6. PubMed ID: 16102037
[TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor directly interacts with DNA from neutrophil extracellular traps.
Grässle S; Huck V; Pappelbaum KI; Gorzelanny C; Aponte-Santamaría C; Baldauf C; Gräter F; Schneppenheim R; Obser T; Schneider SW
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1382-9. PubMed ID: 24790143
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
Perutelli P; Molinari AC
Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
